Royalty Pharma PLC at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 16, 2023 / 03:40PM GMT
David Reed Risinger - SVB Securities LLC, Research Division - Senior MD

Great. So good morning, everybody, and thank you for joining our next session with Royalty Pharma. My name is Dave Risinger, and I'm responsible for diversified biopharmaceuticals at SVB. And it's very much my pleasure to welcome the company's CFO, Terry Coyne. And I've asked Terry to run through slides for about 15 or 20 minutes, and then we're going to go into some questions.

So with that, let me turn it over to you, Terry.

Terrance Coyne - Royalty Pharma plc - Executive VP & CFO

Great. And thanks, Dave, and to everyone at SVB Securities for hosting us today. If we flip to Slide 3, these are our forward-looking statements. Let's move on to Slide 4. This lays out our vision and our mission. So Royalty Pharma's vision is to be the leading partner funding innovation in life sciences, and our mission is to accelerate innovation in life sciences and transform patient lives globally. We like to remind ourselves that this is our -- this is why we come to work every day, and we think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot